One-stop drug design
MoMed Biotech, in its commitment to offering the highest quality in drug research and development design, has launched a multi-dimensional intelligent technology platform to provide comprehensive one-stop services. MoMed Biotech platform utilizes cutting-edge technologies and covers the entire process of drug design, allowing for efficient and rapid customization of solutions based on your unique individual needs.
-
-
High-performance
Research platform of target protein working mechanism
MoMed Biotech utilizes Nobel Prize-winning computational biology techniques to research ultra-large-scale biomolecular systems. Studies on small molecule drug interactions with DNA or proteins not only reveal molecular-level drug mechanisms but also aid in screening anticancer and antiviral drugs in vitro. This research provides theoretical guidance and insights for designing more effective anticancer and antiviral drugs, supported by their high-performance research service platform.
-
High-throughput
Platform of drug molecule virtual screening
MoMed Biotech, based on its mechanism research design platform, provides a high-throughput virtual screening platform for new drug research and development. With multi-criteria serial screening, including screening that incorporates dynamic information, it completes virtual screening of a drug small molecule library at the scale of billions for specific targets. This process identifies high-quality lead compounds, provides structures of molecules with high affinity and activity, and synthesizes better compound molecules.
-
-
-
High-intelligent
Platform of artificial intelligence drug design
MoMed Biotech innovatively launches a research and development approach driven by the mechanistic study of drug targets, combined with the world's leading generative cutting-edge artificial intelligence model technology and professional antibody PROTAC technology. This approach meets the research and development needs of various types of drugs, including small molecule drugs, biological macromolecules, macromolecule-antibody-small molecule conjugate drugs, PROTACs, and others. For specific targets, using high-throughput virtual screening data, MoMed develops AI drug design models to provide innovative drug molecules with independent intellectual property rights.
-
High-level
Optimization platform of drug molecular design
MoMed Biotech, based on the aforementioned three major platforms, has launched the Drug Molecule Design Optimization Platform, focusing on the stability and practicality of drug molecules. With the expertise of professional drug development scientists, this platform utilizes chemical modifications to improve the desired characteristics of candidate drugs. By combining it with MoMed's existing database and employing a "design-experiment-optimize" iterative optimization approach, it provides high-quality optimization services to generate new effective molecules. This maximizes the drug properties while maintaining similarity to the input molecules, ensuring the successful development of innovative new drugs.
-
-
-
High-scale
Drug molecular fragment database platform
MoMed Biotech's drug molecule fragment database is a highly trusted and innovative service with independent intellectual property rights. It utilizes AI technology to assist in drug molecule design and optimization. By leveraging extensive experimental data and model predictions, it provides rich and reliable information on drug molecule fragments, while also supporting rapid optimization of molecular structures. MoMed is committed to providing efficient and reliable drug molecule design services to accelerate the development process of pharmaceutical research and development.
-
High-efficiency
Multi-pipeline drug R&D platform
MoMed Biotech's drug discovery platform efficiently and innovatively supports parallel development across multiple pipelines. With the best R&D technology, the most stringent quality standards, the most professional service and the use of advanced technical means and strict quality management system, we provide first-class, professional and efficient multi-pipeline drug research and development solutions, and constantly optimize the process and improve efficiency in the process to ensure the maximization of R&D results and achieve a win-win situation.
-
